Conference Coverage

Beware nonopiate meds with high street value


 

EXPERT ANALYSIS FROM ACP INTERNAL MEDICINE

Bupropion

This norepinephrine and dopamine reuptake inhibitor is generally assumed to have low abuse potential. That’s usually true – except in jail and prisons.

“In my patient population, where I have a keen eye to what’s being used on the street, bupropion is not one of the medications that I see very often in my patients who are not incarcerated,” Dr. Walley said. “But in incarcerated settings, it does have a street value.”

Consider safeguards

None of the prescription drugs on Dr. Walley’s problem list is included in prescription monitoring programs, nor are they detectable with standard toxicology testing. This poses a challenge for prescribing physicians.

Before prescribing any of these potentially abusable medications for a given patient, therefore, Dr. Walley considers the underlying risks. For example, an addiction history is a big red flag. So is coprescription of an opioid or another drug that might have synergistic adverse effects. Dr. Walley makes sure there is a solid indication for the medication, and, having prescribed the drug, he wants to see and document clear functional benefit.

Pages

Recommended Reading

Mixed outcomes in analysis of NSAIDs and IBD exacerbation
MDedge Internal Medicine
MDedge Daily News: Shingles boosts stroke risk
MDedge Internal Medicine
ERAS reduced opioid use, improved same-day discharge after gyn surgery
MDedge Internal Medicine
MDedge Daily News: Can a nasal spray reverse suicidality?
MDedge Internal Medicine
VIDEO: Ubrogepant reduced pain, related symptoms of a migraine attack
MDedge Internal Medicine
Adolescents, young adults endorse marijuana for IBD
MDedge Internal Medicine
MDedge Daily News: Physician burnout needs more than yoga
MDedge Internal Medicine
Endometriosis pain stemming from pelvic spasms improved with botulinum toxin
MDedge Internal Medicine
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Internal Medicine
FDA advisory committee votes to recommend update to celecoxib safety labeling
MDedge Internal Medicine